Real-World Experience of Adalimumab in the Treatment of Hidradenitis Suppurativa
Published: 7 December 2020| Version 1 | DOI: 10.17632/pfz95dbvgm.1
Contributors:
,
Alyce Anderson,
Caroline Kettering,
Alicia Mizes,
Timothy Patton
Description
Supplemental Data on Reasons for Adalimumab Treatment Discontinuation and Secondary Treatment Initiated After Adalimumab Treatment Failure